Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
QNRX | US
-0.21
-4.40%
Healthcare
Biotechnology
30/06/2024
02/06/2026
4.56
4.97
4.97
4.56
Quoin Pharmaceuticals Ltd. a clinical stage specialty pharmaceutical company focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003 a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn Virginia.
View LessValue Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
54.6%1 month
54.3%3 months
91.4%6 months
116.1%-
-
0.45
0.43
0.23
-0.42
-
-
-8.84M
18.15M
18.15M
-
-
-
-
-100.03
0.01
0.38
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.95
Range1M
2.14
Range3M
6.28
Rel. volume
1.13
Price X volume
141.44K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Enveric Biosciences Inc | ENVB | Biotechnology | 2.22 | 19.80M | -1.77% | n/a | 0.00% |
| Reviva Pharmaceuticals Holdings Inc. | RVPH | Biotechnology | 0.595 | 19.69M | -0.83% | n/a | 0.00% |
| Outlook Therapeutics Inc | OTLK | Biotechnology | 0.8136 | 19.25M | -3.49% | n/a | -39.11% |
| Can-Fite BioPharma Ltd | CANF | Biotechnology | 3.11 | 18.96M | -4.01% | n/a | 0.00% |
| Werewolf Therapeutics Inc. Common Stock | HOWL | Biotechnology | 0.4301 | 18.80M | -7.70% | n/a | 35.26% |
| DarT Bioscience Inc | DARE | Biotechnology | 2.14 | 18.29M | -2.28% | 0.12 | 218.34% |
| Enlivex Therapeutics Ltd | ENLV | Biotechnology | 0.8499 | 18.19M | -1.56% | n/a | 2.92% |
| GeoVax Labs Inc | GOVX | Biotechnology | 2.1 | 17.90M | -4.98% | n/a | -6.03% |
| Inhibikase Therapeutics Inc. | IKT | Biotechnology | 1.7 | 16.96M | -0.58% | n/a | 3.49% |
| Aligos Therapeutics Inc | ALGS | Biotechnology | 5.25 | 16.78M | -1.87% | n/a | 14.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.11 | 16.22M | -2.63% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4275 | 8.26M | -0.47% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.71 | 4.37M | 1.18% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0063 | 580.95K | 12.50% | n/a | -37.05% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4821 | 265.64K | -11.54% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.42 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.45 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 91.42 | - | Riskier |
| Debt to Equity | 0.43 | -1.23 | Expensive |
| Debt to Assets | 0.23 | 0.25 | Par |
| Market Cap | 18.15M | - | Emerging |